These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease. Kim W, Kim J, Jung D, Kim H, Choi HJ, Cho HR, Kwon B. Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721 [Abstract] [Full Text] [Related]
15. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Salat C, Holler E, Kolb HJ, Pihusch R, Reinhardt B, Hiller E. Bone Marrow Transplant; 1997 May; 19(9):909-14. PubMed ID: 9156265 [Abstract] [Full Text] [Related]
17. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease. Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B. Transplantation; 2008 Jan 15; 85(1):102-11. PubMed ID: 18192919 [Abstract] [Full Text] [Related]
20. A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease. Massi D, Franchi A, Pimpinelli N, Laszlo D, Bosi A, Santucci M. Am J Clin Pathol; 1999 Dec 15; 112(6):791-800. PubMed ID: 10587702 [Abstract] [Full Text] [Related] Page: [Next] [New Search]